Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Sell
14,439
-61
-0.4% -$7.14K 1.17% 23
2026
Q1
$1.74M Sell
14,500
-98
-0.7% -$11.3K 1.18% 25
2025
Q4
$1.54M Hold
14,598
1.09% 25
2025
Q3
$1.23M Hold
14,598
0.91% 34
2025
Q2
$1.16M Hold
14,598
0.91% 31
2025
Q1
$1.31M Sell
14,598
-691
-5% -$64.5K 1.07% 27
2024
Q4
$1.52M Sell
15,289
-225
-1% -$23.2K 1.28% 22
2024
Q3
$1.76M Sell
15,514
-167
-1% -$19.8K 1.43% 19
2024
Q2
$1.94M Buy
+15,681
New +$2.02M 1.65% 15

Other funds holding MRK

Bank & Trust Company's MRK Position: Q2 2026 in Review

Bank & Trust Company reduced its Merck (MRK) stake by 0.42% in Q2 2026, selling an estimated $7.14K and leaving 14,439 shares worth $1.86M. The position accounts for 1.17% of the portfolio, ranked #23.

Bank & Trust Company first reported a position in MRK in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.94M in Q2 2024. 1,855 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Bank & Trust Company held 14,439 shares of Merck worth $1.86M as of Q2 2026.
  • Bank & Trust Company sold 61 Merck shares in Q2 2026, an estimated $7.14K.
  • Merck made up 1.17% of Bank & Trust Company's portfolio in Q2 2026, its #23 holding.
  • Bank & Trust Company first reported a position in Merck in Q2 2024 and has held it in 9 quarters since.
  • Bank & Trust Company's Merck position peaked at $1.94M in Q2 2024.
  • 1,855 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bank & Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.